3D-MRE and 2D-MRE for Assessing Cirrhosis and Portal Hypertension

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

August 16, 2022

Primary Completion Date

August 1, 2025

Study Completion Date

December 1, 2025

Conditions
CirrhosisLiver Portal Hypertension
Interventions
DEVICE

3D-MRE

All imaging studies were performed by using a 3.0-T MRI system (Signa HDx, GE Healthcare) with an eight-channel phasedarray body coil.

DEVICE

HVPG

HVPG measurements are performed by well-trained interventional radiologists in accordance with standard operating procedures

DEVICE

2D-MRE

All imaging studies were performed by using a 3.0-T MRI system (Signa HDx, GE Healthcare) with an eight-channel phasedarray body coil.

DEVICE

HVPG

HVPG measurements are performed by well-trained interventional radiologists in accordance with standard operating procedures

Trial Locations (1)

110004

RECRUITING

Shengjing Hospital of China Medical University, Shenyang

All Listed Sponsors
lead

Shengjing Hospital

OTHER